The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to ...

Game-changer' drug Hiprex is set to be approved for NHS use - but there is still no official guidance for treating chronic ...

The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) ...

Treatment MarketThe global urinary tract infection (UTI) treatment market is poised for consistent growth, with an estimated ...

If you’re one of the many people in the world who experiences recurrent UTIs, you may be seeking natural and alternative solutions to avoid excessive exposure to antibiotic drugs. Here are 8 ...

The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections ...

Recently, media personality Abbie Chatfield posted on TikTok explaining she was starting a vaccine to help prevent UTIs. So ...

When it comes to managing urinary tract infections (UTIs), patients often turn to over-the-counter (OTC) products in search of quick relief. However, recent research suggests some products promise ...

Nonantibiotic prophylactic options for UTIs such as methenamine hippurate remain significantly underutilized, especially for ...

Veterinarians should become familiar with new definitions and recommendations for managing urinary tract infections in dogs ...

A group of experts who reviewed evidence on urinary tract infections (UTIs) failed to come up with many recommendations due ...

Orlynvah is the first oral penem approved in the U.S. and Iterum Therapeutics’ first FDA-approved product. CEO Corey Fishman ...